Prudential Financial’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.2M Sell
18,608
-580
-3% -$40.9K ﹤0.01% 1535
2025
Q4
$1.29M Sell
19,188
-49,483
-72% -$3.33M ﹤0.01% 1510
2025
Q3
$5.04M Sell
68,671
-89,265
-57% -$5.93M 0.01% 935
2025
Q2
$8.22M Sell
157,936
-30,190
-16% -$1.72M 0.01% 708
2025
Q1
$12M Sell
188,126
-35,162
-16% -$2.04M 0.02% 530
2024
Q4
$10.7M Sell
223,288
-7,275
-3% -$373K 0.01% 586
2024
Q3
$13.2M Buy
230,563
+49,892
+28% +$2.86M 0.02% 575
2024
Q2
$9.46M Sell
180,671
-42,534
-19% -$1.87M 0.01% 663
2024
Q1
$9.08M Buy
223,205
+85,465
+62% +$3.2M 0.01% 718
2023
Q4
$5.09M Buy
137,740
+95,128
+223% +$3.58M 0.01% 916
2023
Q3
$1.63M Buy
42,612
+22,144
+108% +$907K ﹤0.01% 1493
2023
Q2
$738K Sell
20,468
-2,072
-9% -$70.7K ﹤0.01% 1956
2023
Q1
$1M Buy
22,540
+336
+2% +$15.8K ﹤0.01% 1743
2022
Q4
$1.26M Sell
22,204
-22,672
-51% -$1.16M ﹤0.01% 1580
2022
Q3
$1.77M Sell
44,876
-270,353
-86% -$11.9M ﹤0.01% 1399
2022
Q2
$13.9M Buy
315,229
+229,934
+270% +$9.94M 0.02% 564
2022
Q1
$3.4M Sell
85,295
-24,989
-23% -$890K ﹤0.01% 1201
2021
Q4
$4.43M Sell
110,284
-940
-0.8% -$35.1K 0.01% 1086
2021
Q3
$4.53M Buy
111,224
+31,607
+40% +$1.32M 0.01% 1037
2021
Q2
$3.62M Buy
79,617
+40,331
+103% +$1.79M 0.01% 1175
2021
Q1
$1.64M Sell
39,286
-241,958
-86% -$11M ﹤0.01% 1562
2020
Q4
$12M Buy
281,244
+118,771
+73% +$4.27M 0.02% 670
2020
Q3
$4.27M Sell
162,473
-181,672
-53% -$5.06M 0.01% 993
2020
Q2
$9.23M Sell
344,145
-99,820
-22% -$2.25M 0.02% 720
2020
Q1
$7.99M Buy
443,965
+92,442
+26% +$1.75M 0.02% 729
2019
Q4
$6.23M Buy
351,523
+325,155
+1,233% +$5.63M 0.01% 1037
2019
Q3
$409K Buy
26,368
+9,652
+58% +$159K ﹤0.01% 2108
2019
Q2
$287K Buy
16,716
+3,750
+29% +$60.5K ﹤0.01% 2240
2019
Q1
$209K Buy
12,966
+160
+1% +$2.59K ﹤0.01% 2310
2018
Q4
$187K Sell
12,806
-320,076
-96% -$5.11M ﹤0.01% 2255
2018
Q3
$6.05M Sell
332,882
-760,248
-70% -$13.3M 0.01% 1109
2018
Q2
$18.4M Sell
1,093,130
-302,060
-22% -$5.71M 0.03% 656
2018
Q1
$27.3M Buy
1,395,190
+485,904
+53% +$9.41M 0.04% 498
2017
Q4
$18.4M Buy
909,286
+896,610
+7,073% +$16.5M 0.03% 681
2017
Q3
$220K Buy
12,676
+950
+8% +$12.9K ﹤0.01% 2236
2017
Q2
$150K Buy
11,726
+940
+9% +$12.6K ﹤0.01% 2279
2017
Q1
$140K Hold
10,786
﹤0.01% 2272
2016
Q4
$107K Sell
10,786
-1,100
-9% -$12K ﹤0.01% 2289
2016
Q3
$144K Buy
11,886
+720
+6% +$7.36K ﹤0.01% 2245
2016
Q2
$96K Sell
11,166
-91,200
-89% -$900K ﹤0.01% 2253
2016
Q1
$969K Sell
102,366
-559,800
-85% -$5.27M ﹤0.01% 1824
2015
Q4
$11.5M Buy
662,166
+185,100
+39% +$2.95M 0.02% 739
2015
Q3
$6.41M Buy
477,066
+335,100
+236% +$6.73M 0.01% 917
2015
Q2
$3.21M Buy
141,966
+111,300
+363% +$1.96M 0.01% 1325
2015
Q1
$438K Buy
30,666
+19,500
+175% +$281K ﹤0.01% 2013
2014
Q4
$108K Sell
11,166
-1,400
-11% -$12.4K ﹤0.01% 2149
2014
Q3
$114K Sell
12,566
-12,123
-49% -$115K ﹤0.01% 2164
2014
Q2
$244K Buy
24,689
+12,563
+104% +$107K ﹤0.01% 2234
2014
Q1
$154K Buy
12,126
+300
+3% +$4.45K ﹤0.01% 2188
2013
Q4
$177K Sell
11,826
-2,800
-19% -$36K ﹤0.01% 2197
2013
Q3
$161K Buy
14,626
+300
+2% +$2.5K ﹤0.01% 2188
2013
Q2
$114K Buy
+14,326
New +$91.2K ﹤0.01% 2211

Other funds holding HALO

Prudential Financial's HALO Position: Q1 2026 in Review

Prudential Financial reduced its Halozyme (HALO) stake by 3% in Q1 2026, selling an estimated $40.9K and leaving 18,608 shares worth $1.2M. The position accounts for ﹤0.01% of the portfolio, ranked #1535.

Prudential Financial first reported a position in HALO in Q2 2013 and has held it in 52 quarters since. The position peaked at $27.3M in Q1 2018. 634 funds tracked by Wall St. Rank hold HALO as of Q1 2026.

  • Prudential Financial held 18,608 shares of Halozyme worth $1.2M as of Q1 2026.
  • Prudential Financial sold 580 Halozyme shares in Q1 2026, an estimated $40.9K.
  • Halozyme made up ﹤0.01% of Prudential Financial's portfolio in Q1 2026, its #1535 holding.
  • Prudential Financial first reported a position in Halozyme in Q2 2013 and has held it in 52 quarters since.
  • Prudential Financial's Halozyme position peaked at $27.3M in Q1 2018.
  • 634 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.

Based on Prudential Financial's 13F filing for Q1 2026, filed 13 May 2026.